Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
FXC00116
|
FHC00116
|
FNC00116N
|
FNC00116C
|
TAOK1 |
TAO kinase 1, transcript variant 1 |
FXC00219
|
FHC00219
|
FNC00219N
|
FNC00219C
|
FASN |
fatty acid synthase |
FXC00314
|
FHC00314
|
FNC00314N
|
FNC00314C
|
RAPGEF2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
FXC00500
|
FHC00500
|
FNC00500N
|
FNC00500C
|
CACNA2D2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2, transcript variant 1 |
FXC00563
|
FHC00563
|
FNC00563N
|
FNC00563C
|
TAB2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2, transcript variant 1 |
FXC00616
|
FHC00616
|
FNC00616N
|
FNC00616C
|
RASGRP3 |
RAS guanyl releasing protein 3 (calcium and DAG-regulated), transcript variant 3 |
FXC00656
|
FHC00656
|
FNC00656N
|
FNC00656C
|
TAOK2 |
TAO kinase 2, transcript variant 2 |
FXC00670
|
FHC00670
|
FNC00670N
|
FNC00670C
|
MAPK8IP3 |
mitogen-activated protein kinase 8 interacting protein 3, transcript variant 1 |
FXC00728
|
FHC00728
|
FNC00728N
|
FNC00728C
|
TP53BP1 |
tumor protein p53 binding protein 1, transcript variant 2 |
FXC00998
|
FHC00998
|
FNC00998N
|
FNC00998C
|
SYNGAP1 |
synaptic Ras GTPase activating protein 1 |
FXC01186
|
FHC01186
|
FNC01186N
|
FNC01186C
|
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
FXC01272
|
FHC01272
|
FNC01272N
|
FNC01272C
|
NFKB2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100), transcript variant 2 |
FXC01287
|
FHC01287
|
FNC01287N
|
FNC01287C
|
ZAK |
sterile alpha motif and leucine zipper containing kinase AZK, transcript variant 1 |
FXC01289
|
FHC01289
|
FNC01289N
|
FNC01289C
|
TGFBR1 |
transforming growth factor, beta receptor 1, transcript variant 1 |
FXC01305
|
FHC01305
|
FNC01305N
|
FNC01305C
|
MAPK14 |
mitogen-activated protein kinase 14, transcript variant 1 |
FXC01309
|
FHC01309
|
FNC01309N
|
FNC01309C
|
NLK |
nemo-like kinase |
FXC01310
|
FHC01310
|
FNC01310N
|
FNC01310C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
FXC01323
|
FHC01323
|
FNC01323N
|
FNC01323C
|
MAP4K3 |
mitogen-activated protein kinase kinase kinase kinase 3, transcript variant 1 |
FXC01352
|
FHC01352
|
FNC01352N
|
FNC01352C
|
MEF2C |
myocyte enhancer factor 2C, transcript variant 1 |
FXC01355
|
FHC01355
|
FNC01355N
|
FNC01355C
|
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
FXC01384
|
FHC01384
|
FNC01384N
|
FNC01384C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa), transcript variant 2 |
FXC01401
|
FHC01401
|
FNC01401N
|
FNC01401C
|
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
FXC01412
|
FHC01412
|
FNC01412N
|
FNC01412C
|
PPP3CC |
protein phosphatase 3, catalytic subunit, gamma isozyme, transcript variant 2 |
FXC01443
|
FHC01443
|
FNC01443N
|
FNC01443C
|
MAP2K5 |
mitogen-activated protein kinase kinase 5, transcript variant 1 |
FXC01455
|
FHC01455
|
FNC01455N
|
FNC01455C
|
GRB2 |
growth factor receptor-bound protein 2, transcript variant 1 |
FXC01485
|
FHC01485
|
FNC01485N
|
FNC01485C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
IKBKG |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma, transcript variant 3 |
FXC01524
|
FHC01524
|
FNC01524N
|
FNC01524C
|
NCOA3 |
nuclear receptor coactivator 3, transcript variant 3 |
FXC01529
|
FHC01529
|
FNC01529N
|
FNC01529C
|
JUN |
jun proto-oncogene |
FXC01532
|
FHC01532
|
FNC01532N
|
FNC01532C
|
TRAF6 |
TNF receptor-associated factor 6, E3 ubiquitin protein ligase, transcript variant 2 |
FXC01545
|
FHC01545
|
FNC01545N
|
FNC01545C
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
FXC01574
|
FHC01574
|
FNC01574N
|
FNC01574C
|
MAP3K2 |
mitogen-activated protein kinase kinase kinase 2 |
FXC01733
|
FHC01733
|
FNC01733N
|
FNC01733C
|
RPS6KA2 |
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
FXC01745
|
FHC01745
|
FNC01745N
|
FNC01745C
|
ATF2 |
activating transcription factor 2, transcript variant 1 |
FXC01751
|
FHC01751
|
FNC01751N
|
FNC01751C
|
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1, transcript variant 1 |
FXC01797
|
FHC01797
|
FNC01797N
|
FNC01797C
|
PPM1A |
protein phosphatase, Mg2+/Mn2+ dependent, 1A, transcript variant 1 |
FXC01828
|
FHC01828
|
FNC01828N
|
FNC01828C
|
RASGRF1 |
Ras protein-specific guanine nucleotide-releasing factor 1, transcript variant 3 |
FXC01848
|
FHC01848
|
FNC01848N
|
FNC01848C
|
PPP3CA |
protein phosphatase 3, catalytic subunit, alpha isozyme, transcript variant 2 |
FXC01927
|
FHC01927
|
FNC01927N
|
FNC01927C
|
PTPN5 |
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched), transcript variant 1 |
FXC01928
|
FHC01928
|
FNC01928N
|
FNC01928C
|
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
FXC01934
|
FHC01934
|
FNC01934N
|
FNC01934C
|
DUSP16 |
dual specificity phosphatase 16 |
FXC02049
|
FHC02049
|
FNC02049N
|
FNC02049C
|
MAX |
MYC associated factor X, transcript variant 1 |
FXC02095
|
FHC02095
|
FNC02095N
|
FNC02095C
|
GNA12 |
guanine nucleotide binding protein (G protein) alpha 12, transcript variant 1 |
FXC02119
|
FHC02119
|
FNC02119N
|
FNC02119C
|
ARRB1 |
arrestin, beta 1, transcript variant 1 |
FXC02162
|
FHC02162
|
FNC02162N
|
FNC02162C
|
GNG12 |
guanine nucleotide binding protein (G protein), gamma 12 |
FXC02211
|
FHC02211
|
FNC02211N
|
FNC02211C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
PDGFA |
platelet-derived growth factor alpha polypeptide, transcript variant 2 |
FXC02363
|
FHC02363
|
FNC02363N
|
FNC02363C
|
SOS2 |
son of sevenless homolog 2 (Drosophila) |
FXC02373
|
FHC02373
|
FNC02373N
|
FNC02373C
|
SOS1 |
son of sevenless homolog 1 (Drosophila) |
FXC02380
|
FHC02380
|
FNC02380N
|
FNC02380C
|
KCNH4 |
potassium channel, voltage gated eag related subfamily H, member 4 |
FXC02382
|
FHC02382
|
FNC02382N
|
FNC02382C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
PPM1B |
protein phosphatase, Mg2+/Mn2+ dependent, 1B, transcript variant 1 |
FXC02617
|
FHC02617
|
FNC02617N
|
FNC02617C
|
STMN1 |
stathmin 1, transcript variant 3 |
FXC02683
|
FHC02683
|
FNC02683N
|
FNC02683C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
MAP3K3 |
mitogen-activated protein kinase kinase kinase 3, transcript variant 1 |
FXC02739
|
FHC02739
|
FNC02739N
|
FNC02739C
|
GADD45A |
growth arrest and DNA-damage-inducible, alpha, transcript variant 1 |
FXC02792
|
FHC02792
|
FNC02792N
|
FNC02792C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta, transcript variant 3 |
FXC02835
|
FHC02835
|
FNC02835N
|
FNC02835C
|
CRKL |
v-crk avian sarcoma virus CT10 oncogene homolog-like |
FXC02842
|
FHC02842
|
FNC02842N
|
FNC02842C
|
MAPK11 |
mitogen-activated protein kinase 11, transcript variant 1 |
FXC02847
|
FHC02847
|
FNC02847N
|
FNC02847C
|
RAC2 |
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
FXC02856
|
FHC02856
|
FNC02856N
|
FNC02856C
|
RAP1B |
RAP1B, member of RAS oncogene family, transcript variant 1 |
FXC02891
|
FHC02891
|
FNC02891N
|
FNC02891C
|
GDNF |
glial cell derived neurotrophic factor, transcript variant 1 |
FXC03087
|
FHC03087
|
FNC03087N
|
FNC03087C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
NR4A1 |
nuclear receptor subfamily 4, group A, member 1 |
FXC03212
|
FHC03212
|
FNC03212N
|
FNC03212C
|
NTF4 |
neurotrophin 4 |
FXC03305
|
FHC03305
|
FNC03305N
|
FNC03305C
|
BDNF |
brain-derived neurotrophic factor, transcript variant 4 |
FXC03322
|
FHC03322
|
FNC03322N
|
FNC03322C
|
NTF3 |
neurotrophin 3, transcript variant 2 |
FXC03324
|
FHC03324
|
FNC03324N
|
FNC03324C
|
MOS |
v-mos Moloney murine sarcoma viral oncogene homolog |
FXC03345
|
FHC03345
|
FNC03345N
|
FNC03345C
|
FLNA |
filamin A, alpha, transcript variant 1 |
FXC03392
|
FHC03392
|
FNC03392N
|
FNC03392C
|
PPP5C |
protein phosphatase 5, catalytic subunit, transcript variant 1 |
FXC03434
|
FHC03434
|
FNC03434N
|
FNC03434C
|
ECSIT |
ECSIT signalling integrator, transcript variant 1 |
FXC03508
|
FHC03508
|
FNC03508N
|
FNC03508C
|
ARRB2 |
arrestin, beta 2, transcript variant 1 |
FXC03515
|
FHC03515
|
FNC03515N
|
FNC03515C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
PTPN7 |
protein tyrosine phosphatase, non-receptor type 7, transcript variant 1 |
FXC03523
|
FHC03523
|
FNC03523N
|
FNC03523C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03542
|
FHC03542
|
FNC03542N
|
FNC03542C
|
PRKCA |
protein kinase C, alpha |
FXC03611
|
FHC03611
|
FNC03611N
|
FNC03611C
|
HRAS |
Harvey rat sarcoma viral oncogene homolog, transcript variant 1 |
FXC03635
|
FHC03635
|
FNC03635N
|
FNC03635C
|
DAXX |
death-domain associated protein, transcript variant 2 |
FXC03646
|
FHC03646
|
FNC03646N
|
FNC03646C
|
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, transcript variant 1 |
FXC03657
|
FHC03657
|
FNC03657N
|
FNC03657C
|
PRKCG |
protein kinase C, gamma |
FXC03659
|
FHC03659
|
FNC03659N
|
FNC03659C
|
PKN1 |
protein kinase N1, transcript variant 1 |
FXC03745
|
FHC03745
|
FNC03745N
|
FNC03745C
|
MAPK7 |
mitogen-activated protein kinase 7, transcript variant 3 |
FXC03754
|
FHC03754
|
FNC03754N
|
FNC03754C
|
PKN2 |
protein kinase N2 |
FXC03784
|
FHC03784
|
FNC03784N
|
FNC03784C
|
MKNK2 |
MAP kinase interacting serine/threonine kinase 2, transcript variant 2 |
FXC03791
|
FHC03791
|
FNC03791N
|
FNC03791C
|
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8, transcript variant 1 |
FXC03793
|
FHC03793
|
FNC03793N
|
FNC03793C
|
MECOM |
MDS1 and EVI1 complex locus |
FXC03843
|
FHC03843
|
FNC03843N
|
FNC03843C
|
PPP3R1 |
protein phosphatase 3, regulatory subunit B, alpha |
FXC03887
|
FHC03887
|
FNC03887N
|
FNC03887C
|
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent), transcript variant 1 |
FXC03961
|
FHC03961
|
FNC03961N
|
FNC03961C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC03984
|
FHC03984
|
FNC03984N
|
FNC03984C
|
ATF4 |
activating transcription factor 4, transcript variant 1 |
FXC04200
|
FHC04200
|
FNC04200N
|
FNC04200C
|
CACNG2 |
calcium channel, voltage-dependent, gamma subunit 2 |
FXC04418
|
FHC04418
|
FNC04418N
|
FNC04418C
|
CD14 |
CD14 molecule, transcript variant 1 |
FXC04493
|
FHC04493
|
FNC04493N
|
FNC04493C
|
DUSP1 |
dual specificity phosphatase 1 |
FXC04837
|
FHC04837
|
FNC04837N
|
FNC04837C
|
DUSP4 |
dual specificity phosphatase 4, transcript variant 1 |
FXC04844
|
FHC04844
|
FNC04844N
|
FNC04844C
|
DUSP6 |
dual specificity phosphatase 6, transcript variant 1 |
FXC04845
|
FHC04845
|
FNC04845N
|
FNC04845C
|
FAS |
Fas cell surface death receptor |
FXC04988
|
FHC04988
|
FNC04988N
|
FNC04988C
|
FGF5 |
fibroblast growth factor 5, transcript variant 1 |
FXC05019
|
FHC05019
|
FNC05019N
|
FNC05019C
|
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
FXC05255
|
FHC05255
|
FNC05255N
|
FNC05255C
|
HSPA1L |
heat shock 70kDa protein 1-like |
FXC05465
|
FHC05465
|
FNC05465N
|
FNC05465C
|
IL1A |
interleukin 1, alpha |
FXC05509
|
FHC05509
|
FNC05509N
|
FNC05509C
|
IL1B |
interleukin 1, beta |
FXC05510
|
FHC05510
|
FNC05510N
|
FNC05510C
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
FXC05918
|
FHC05918
|
FNC05918N
|
FNC05918C
|
MAP3K4 |
mitogen-activated protein kinase kinase kinase 4, transcript variant 2 |
FXC05920
|
FHC05920
|
FNC05920N
|
FNC05920C
|
MAP4K1 |
mitogen-activated protein kinase kinase kinase kinase 1, transcript variant 2 |
FXC05924
|
FHC05924
|
FNC05924N
|
FNC05924C
|
MAPK12 |
mitogen-activated protein kinase 12, transcript variant 2 |
FXC05927
|
FHC05927
|
FNC05927N
|
FNC05927C
|
MAPK13 |
mitogen-activated protein kinase 13, transcript variant 1 |
FXC05928
|
FHC05928
|
FNC05928N
|
FNC05928C
|
DDIT3 |
DNA-damage-inducible transcript 3, transcript variant 5 |
FXC06075
|
FHC06075
|
FNC06075N
|
FNC06075C
|
PDGFB |
platelet-derived growth factor beta polypeptide, transcript variant 1 |
FXC06311
|
FHC06311
|
FNC06311N
|
FNC06311C
|
PLA2G4D |
phospholipase A2, group IVD (cytosolic) |
FXC06382
|
FHC06382
|
FNC06382N
|
FNC06382C
|
PRKACG |
protein kinase, cAMP-dependent, catalytic, gamma |
FXC06481
|
FHC06481
|
FNC06481N
|
FNC06481C
|
RAP1A |
RAP1A, member of RAS oncogene family, transcript variant 2 |
FXC06588
|
FHC06588
|
FNC06588N
|
FNC06588C
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A, transcript variant 1 |
FXC06624
|
FHC06624
|
FNC06624N
|
FNC06624C
|
RPS6KA6 |
ribosomal protein S6 kinase, 90kDa, polypeptide 6 |
FXC06696
|
FHC06696
|
FNC06696N
|
FNC06696C
|
SRF |
serum response factor (c-fos serum response element-binding transcription factor), transcript variant 1 |
FXC06986
|
FHC06986
|
FNC06986N
|
FNC06986C
|
TANK |
TRAF family member-associated NFKB activator, transcript variant 1 |
FXC07067
|
FHC07067
|
FNC07067N
|
FNC07067C
|
HSPA1A |
heat shock 70kDa protein 1A |
FXC07555
|
FHC07555
|
FNC07555N
|
FNC07555C
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2, transcript variant e |
FXC07750
|
FHC07750
|
FNC07750N
|
FNC07750C
|
NGF |
nerve growth factor (beta polypeptide) |
FXC07757
|
FHC07757
|
FNC07757N
|
FNC07757C
|
DUSP5 |
dual specificity phosphatase 5 |
FXC07761
|
FHC07761
|
FNC07761N
|
FNC07761C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 2 |
FXC07774
|
FHC07774
|
FNC07774N
|
FNC07774C
|
PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme, transcript variant 2 |
FXC07780
|
FHC07780
|
FNC07780N
|
FNC07780C
|
HSPA2 |
heat shock 70kDa protein 2 |
FXC08027
|
FHC08027
|
FNC08027N
|
FNC08027C
|
DUSP3 |
dual specificity phosphatase 3 |
FXC08096
|
FHC08096
|
FNC08096N
|
FNC08096C
|
GPI |
glucose-6-phosphate isomerase, transcript variant 2 |
FXC08209
|
FHC08209
|
FNC08209N
|
FNC08209C
|
FGF18 |
fibroblast growth factor 18 |
FXC08269
|
FHC08269
|
FNC08269N
|
FNC08269C
|
DUSP12 |
dual specificity phosphatase 12 |
FXC08271
|
FHC08271
|
FNC08271N
|
FNC08271C
|
CRK |
v-crk avian sarcoma virus CT10 oncogene homolog, transcript variant II |
FXC08374
|
FHC08374
|
FNC08374N
|
FNC08374C
|
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
FXC08439
|
FHC08439
|
FNC08439N
|
FNC08439C
|
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
FXC08484
|
FHC08484
|
FNC08484N
|
FNC08484C
|
NR4A1 |
nuclear receptor subfamily 4, group A, member 1, transcript variant 1 |
FXC08830
|
FHC08830
|
FNC08830N
|
FNC08830C
|
CASP3 |
caspase 3, apoptosis-related cysteine peptidase, transcript variant alpha |
FXC08865
|
FHC08865
|
FNC08865N
|
FNC08865C
|
FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
CACNG6 |
calcium channel, voltage-dependent, gamma subunit 6, transcript variant 1 |
FXC09061
|
FHC09061
|
FNC09061N
|
FNC09061C
|
FGF12 |
fibroblast growth factor 12, transcript variant 2 |
FXC09106
|
FHC09106
|
FNC09106N
|
FNC09106C
|
TRAF2 |
TNF receptor-associated factor 2 |
FXC09417
|
FHC09417
|
FNC09417N
|
FNC09417C
|
STK24 |
serine/threonine kinase 24, transcript variant 2 |
FXC09574
|
FHC09574
|
FNC09574N
|
FNC09574C
|
EGFR |
epidermal growth factor receptor, transcript variant 1 |
FXC09683
|
FHC09683
|
FNC09683N
|
FNC09683C
|
HSPB1 |
heat shock 27kDa protein 1 |
FXC09723
|
FHC09723
|
FNC09723N
|
FNC09723C
|
NFATC3 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3, transcript variant 1 |
FXC09749
|
FHC09749
|
FNC09749N
|
FNC09749C
|
TAOK3 |
TAO kinase 3 |
FXC09805
|
FHC09805
|
FNC09805N
|
FNC09805C
|
FGFR4 |
fibroblast growth factor receptor 4, transcript variant 1 |
FXC09979
|
FHC09979
|
FNC09979N
|
FNC09979C
|
FGF13 |
fibroblast growth factor 13, transcript variant 1 |
FXC09990
|
FHC09990
|
FNC09990N
|
FNC09990C
|
FGF21 |
fibroblast growth factor 21 |
FXC10096
|
FHC10096
|
FNC10096N
|
FNC10096C
|
DUSP10 |
dual specificity phosphatase 10, transcript variant 1 |
FXC10264
|
FHC10264
|
FNC10264N
|
FNC10264C
|
MAP3K14 |
mitogen-activated protein kinase kinase kinase 14 |
FXC10327
|
FHC10327
|
FNC10327N
|
FNC10327C
|
HSPA6 |
heat shock 70kDa protein 6 (HSP70B') |
FXC10328
|
FHC10328
|
FNC10328N
|
FNC10328C
|
TP53 |
tumor protein p53, transcript variant 1 |
FXC10374
|
FHC10374
|
FNC10374N
|
FNC10374C
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
FXC10375
|
FHC10375
|
FNC10375N
|
FNC10375C
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
FXC10454
|
FHC10454
|
FNC10454N
|
FNC10454C
|
FGFR3 |
fibroblast growth factor receptor 3
|
FXC10468
|
FHC10468
|
|
|
FGFR3 |
fibroblast growth factor receptor 3, transcript variant 1 |
FXC10478
|
FHC10478
|
FNC10478N
|
FNC10478C
|
HSPA8 |
heat shock 70kDa protein 8, transcript variant 1 |
FXC10509
|
FHC10509
|
FNC10509N
|
FNC10509C
|
MAP2K3 |
mitogen-activated protein kinase kinase 3, transcript variant A |
FXC10525
|
FHC10525
|
FNC10525N
|
FNC10525C
|
FGFR1 |
fibroblast growth factor receptor 1, transcript variant 3 |
FXC10532
|
FHC10532
|
FNC10532N
|
FNC10532C
|
PRKCB |
protein kinase C, beta, transcript variant 2 |
FXC10533
|
FHC10533
|
FNC10533N
|
FNC10533C
|
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha, transcript variant 1 |
FXC10564
|
FHC10564
|
FNC10564N
|
FNC10564C
|
FGF1 |
fibroblast growth factor 1 (acidic), transcript variant 1 |
FXC10599
|
FHC10599
|
FNC10599N
|
FNC10599C
|
GADD45B |
growth arrest and DNA-damage-inducible, beta |
FXC10610
|
FHC10610
|
FNC10610N
|
FNC10610C
|
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2, transcript variant 1 |
FXC10622
|
FHC10622
|
FNC10622N
|
FNC10622C
|
RRAS |
related RAS viral (r-ras) oncogene homolog |
FXC10666
|
FHC10666
|
FNC10666N
|
FNC10666C
|
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7, transcript variant A |
FXC10678
|
FHC10678
|
FNC10678N
|
FNC10678C
|
MKNK1 |
MAP kinase interacting serine/threonine kinase 1, transcript variant 3 |
FXC10724
|
FHC10724
|
FNC10724N
|
FNC10724C
|
KRAS |
Kirsten rat sarcoma viral oncogene homolog, transcript variant b |
FXC10770
|
FHC10770
|
FNC10770N
|
FNC10770C
|
PDGFB |
platelet-derived growth factor beta polypeptide |
FXC10772
|
FHC10772
|
FNC10772N
|
FNC10772C
|
FGF11 |
fibroblast growth factor 11, transcript variant 1 |
FXC10818
|
FHC10818
|
FNC10818N
|
FNC10818C
|
CHUK |
conserved helix-loop-helix ubiquitous kinase |
FXC10858
|
FHC10858
|
FNC10858N
|
FNC10858C
|
MRAS |
muscle RAS oncogene homolog, transcript variant 1 |
FXC10922
|
FHC10922
|
FNC10922N
|
FNC10922C
|
TGFB2 |
transforming growth factor, beta 2, transcript variant 1 |
FXC10973
|
FHC10973
|
FNC10973N
|
FNC10973C
|
MAP3K6 |
mitogen-activated protein kinase kinase kinase 6, transcript variant 1 |
FXC11020
|
FHC11020
|
FNC11020N
|
FNC11020C
|
STK4 |
serine/threonine kinase 4 |
FXC11122
|
FHC11122
|
FNC11122N
|
FNC11122C
|
FGF16 |
fibroblast growth factor 16 |
FXC11178
|
FHC11178
|
FNC11178N
|
FNC11178C
|
MAPKAPK3 |
mitogen-activated protein kinase-activated protein kinase 3, transcript variant 3 |
FXC11215
|
FHC11215
|
FNC11215N
|
FNC11215C
|
MAP2K7 |
mitogen-activated protein kinase kinase 7, transcript variant 3 |
FXC11270
|
FHC11270
|
FNC11270N
|
FNC11270C
|
STK3 |
serine/threonine kinase 3 |
FXC11390
|
FHC11390
|
FNC11390N
|
FNC11390C
|
ELK1 |
ELK1, member of ETS oncogene family, transcript variant 2 |
FXC11409
|
FHC11409
|
FNC11409N
|
FNC11409C
|
RASA2 |
RAS p21 protein activator 2, transcript variant 2 |
FXC11430
|
FHC11430
|
FNC11430N
|
FNC11430C
|
NRAS |
neuroblastoma RAS viral (v-ras) oncogene homolog |
FXC11491
|
FHC11491
|
FNC11491N
|
FNC11491C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
CACNG4 |
calcium channel, voltage-dependent, gamma subunit 4 |
FXC11543
|
FHC11543
|
FNC11543N
|
FNC11543C
|
RPS6KA4 |
ribosomal protein S6 kinase, 90kDa, polypeptide 4, transcript variant 3 |
FXC11752
|
FHC11752
|
FNC11752N
|
FNC11752C
|
MAPT |
microtubule-associated protein tau, transcript variant 4 |
FXC11766
|
FHC11766
|
FNC11766N
|
FNC11766C
|
FGF3 |
fibroblast growth factor 3 |
FXC11767
|
FHC11767
|
FNC11767N
|
FNC11767C
|
BRAF |
B-Raf proto-oncogene, serine/threonine kinase |
FXC11883
|
FHC11883
|
FNC11883N
|
FNC11883C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 1 |
FXC11986
|
FHC11986
|
FNC11986N
|
FNC11986C
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2, transcript variant c |
FXC12007
|
FHC12007
|
FNC12007N
|
FNC12007C
|
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1, transcript variant 1 |
FXC12349
|
FHC12349
|
FNC12349N
|
FNC12349C
|
IL1R1 |
interleukin 1 receptor, type I, transcript variant 1 |
FXC12556
|
FHC12556
|
FNC12556N
|
FNC12556C
|
RPS6KA5 |
ribosomal protein S6 kinase, 90kDa, polypeptide 5, transcript variant 1 |
FXC12573
|
FHC12573
|
FNC12573N
|
FNC12573C
|
PDGFRA |
platelet derived growth factor receptor alpha |
FXC12575
|
FHC12575
|
FNC12575N
|
FNC12575C
|
MAP4K2 |
mitogen-activated protein kinase kinase kinase kinase 2 |
FXC12634
|
FHC12634
|
FNC12634N
|
FNC12634C
|
DUSP7 |
dual specificity phosphatase 7 |
FXC12730
|
FHC12730
|
FNC12730N
|
FNC12730C
|
RASA1 |
RAS p21 protein activator (GTPase activating protein) 1, transcript variant 1 |
FXC13661
|
FHC13661
|
FNC13661N
|
FNC13661C
|
CACNA1G |
calcium channel, voltage-dependent, T type, alpha 1G subunit, transcript variant 1 |
FXC15883
|
FHC15883
|
FNC15883N
|
FNC15883C
|
CACNA1I |
calcium channel, voltage-dependent, T type, alpha 1I subunit, transcript variant 1 |
FXC15884
|
FHC15884
|
FNC15884N
|
FNC15884C
|
CACNG7 |
calcium channel, voltage-dependent, gamma subunit 7 |
FXC15891
|
FHC15891
|
FNC15891N
|
FNC15891C
|
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
FXC16509
|
FHC16509
|
FNC16509N
|
FNC16509C
|
PTPRR |
protein tyrosine phosphatase, receptor type, R, transcript variant 2 |
FXC16533
|
FHC16533
|
FNC16533N
|
FNC16533C
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1, transcript variant 2 |
FXC20642
|
FHC20642
|
FNC20642N
|
FNC20642C
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1, transcript variant 2 |
FXC20644
|
FHC20644
|
|
|
ELK4 |
ELK4, ETS-domain protein (SRF accessory protein 1), transcript variant a |
FXC20788
|
FHC20788
|
FNC20788N
|
FNC20788C
|
MAPKAPK2 |
mitogen-activated protein kinase-activated protein kinase 2, transcript variant 2 |
FXC20795
|
FHC20795
|
FNC20795N
|
FNC20795C
|
IL1R2 |
interleukin 1 receptor, type II, transcript variant 1 |
FXC21118
|
FHC21118
|
FNC21118N
|
FNC21118C
|
ZAK |
sterile alpha motif and leucine zipper containing kinase AZK, transcript variant 2 |
FXC21226
|
FHC21226
|
FNC21226N
|
FNC21226C
|
KCNH8 |
potassium channel, voltage gated eag related subfamily H, member 8 |
FXC21449
|
FHC21449
|
FNC21449N
|
FNC21449C
|
MAP3K13 |
mitogen-activated protein kinase kinase kinase 13, transcript variant 1 |
FXC21785
|
FHC21785
|
FNC21785N
|
FNC21785C
|
FGF10 |
fibroblast growth factor 10 |
FXC22164
|
FHC22164
|
FNC22164N
|
FNC22164C
|
FGF20 |
fibroblast growth factor 20 |
FXC23199
|
FHC23199
|
FNC23199N
|
FNC23199C
|
FGF17 |
fibroblast growth factor 17, transcript variant 1 |
FXC23209
|
FHC23209
|
FNC23209N
|
FNC23209C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 1 |
FXC24041
|
FHC24041
|
FNC24041N
|
FNC24041C
|
FGFR2 |
fibroblast growth factor receptor 2, transcript variant 9 |
FXC24045
|
FHC24045
|
|
|
MAP3K11 |
mitogen-activated protein kinase kinase kinase 11 |
FXC24308
|
FHC24308
|
FNC24308N
|
FNC24308C
|
FGF19 |
fibroblast growth factor 19 |
FXC24356
|
FHC24356
|
FNC24356N
|
FNC24356C
|
FGF4 |
fibroblast growth factor 4 |
FXC24357
|
FHC24357
|
FNC24357N
|
FNC24357C
|
FGF23 |
fibroblast growth factor 23
|
FXC24560
|
FHC24560
|
|
|
MAP3K12 |
mitogen-activated protein kinase kinase kinase 12, transcript variant 2 |
FXC24753
|
FHC24753
|
FNC24753N
|
FNC24753C
|
FGF9 |
fibroblast growth factor 9 |
FXC24958
|
FHC24958
|
FNC24958N
|
FNC24958C
|
FGF14 |
fibroblast growth factor 14, transcript variant 2 |
FXC25055
|
FHC25055
|
FNC25055N
|
FNC25055C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
TGFB3 |
transforming growth factor, beta 3 |
FXC25244
|
FHC25244
|
FNC25244N
|
FNC25244C
|
FGF7 |
fibroblast growth factor 7 |
FXC25383
|
FHC25383
|
FNC25383N
|
FNC25383C
|
CACNG3 |
calcium channel, voltage-dependent, gamma subunit 3 |
FXC25636
|
FHC25636
|
FNC25636N
|
FNC25636C
|
MAP2K4 |
mitogen-activated protein kinase kinase 4, transcript variant 1 |
FXC25904
|
FHC25904
|
FNC25904N
|
FNC25904C
|
CACNG1 |
calcium channel, voltage-dependent, gamma subunit 1 |
FXC26161
|
FHC26161
|
FNC26161N
|
FNC26161C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated), transcript variant 2 |
FXC28050
|
FHC28050
|
FNC28050N
|
FNC28050C
|
JUND |
jun D proto-oncogene, transcript variant 1 |
FXC28593
|
FHC28593
|
FNC28593N
|
FNC28593C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
CACNA1F |
calcium channel, voltage-dependent, L type, alpha 1F subunit, transcript variant 1 |
FXC29434
|
FHC29434
|
FNC29434N
|
FNC29434C
|
FLNC |
filamin C, gamma, transcript variant 1 |
FXC30232
|
FHC30232
|
FNC30232N
|
FNC30232C
|
CACNA2D4 |
calcium channel, voltage-dependent, alpha 2/delta subunit 4 |
FXC30516
|
FHC30516
|
FNC30516N
|
FNC30516C
|
MAPKAPK5 |
mitogen-activated protein kinase-activated protein kinase 5, transcript variant 1 |
FXC30551
|
FHC30551
|
FNC30551N
|
FNC30551C
|
CACNA1H |
calcium channel, voltage-dependent, T type, alpha 1H subunit, transcript variant 1 |
FXC30646
|
FHC30646
|
FNC30646N
|
FNC30646C
|
RASGRP4 |
RAS guanyl releasing protein 4, transcript variant a |
FXC30817
|
FHC30817
|
FNC30817N
|
FNC30817C
|
RELB |
v-rel avian reticuloendotheliosis viral oncogene homolog B |
FXC30830
|
FHC30830
|
FNC30830N
|
FNC30830C
|
TAB1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1, transcript variant alpha |
FXC31603
|
FHC31603
|
FNC31603N
|
FNC31603C
|